SKIP TO CHAPTER SKIP TO CHAPTER

What Are Galactooligosaccharides (GOS)?

Galactooligosaccharides, or GOS, is a collective term for a commercially produced carbohydrate designed to mimic the oligosaccharides that occur naturally in human breast milk. GOS may help promote good bacteria in the gut.1 GOS acts as soluble fibre and is shown to promote soft stools in infants that are formula-fed or supplemented.1

What Is Polydextrose?

Polydextrose is another type of non-digestible oligosaccharide that is used as a dietary fibre.2 This type of dietary fibre may promote naturally occurring good bacteria like Bifidobacteria.2

Polydextrose may also have the following positive effects:2

  • Help support the immune system

While there may be additional health benefits of an infant formula containing polydextrose, this dietary fiber has also been shown to soften stools.

You may need to supplement with formula or may need to exclusively formula-feed. When making that decision for your baby, ensure that you’re giving your little one an excellent start in life, and discuss the option of choosing a formula that contains polydextrose and GOS with your baby's physician. These dietary fibres can help support your baby’s immune system by promoting the growth of good bacteria in the gut and soften your baby’s stools.

Enfamil A+ contains the exclusive DuoFibre blend that promotes the immune-supporting bacteria in your baby’s gut.3,4

Enfamil A+ contains our exclusive DuoFibre blend* that feeds immune-supporting bacteria in your baby’s gut.**

* Enfamil A+ infant formula compared to same formula without fibre blend.

** Enfamil A+ has a fibre blend that can help promote good bacteria. Good bacteria help support the immune system.

* Blend of polydextrose and GOS. Enfamil A+® has a fibre blend that can help promote good bacteria.

** Good bacteria help support the immune system.

  1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2607002/
  2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037538/
  3. Blend of Polydextrose and GOS
  4. ScalabrinD, et al. JPGN. 2012; 54 : 343-352
Share